CTI Capital logo

CTI Capital

North America, Quebec, Canada, Quebec

Description

CTI Capital is a venture capital fund that invests in development-stage, Canadian life sciences companies.

Investor Profile

CTI Capital has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (40%)
  • Series A (20%)
  • Series C (20%)
  • Series B (20%)

Country Focus

  • Canada (60%)
  • Singapore (20%)
  • Spain (20%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Medical Device
  • Genetics
  • Health Care
  • Medical
  • B2b
  • E-commerce
  • Logistics
  • Consumer Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CTI Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
ABN AMRO Fund
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Domain Associates
North America, California, United States, San Diego
Co-Investments: 1
The Ontario Capital Growth
North America, Ontario, Canada, Toronto
Co-Investments: 1
Desjardins Venture Capital
North America, Quebec, Canada, Lévis
Co-Investments: 1
BDC Venture Capital
North America, Alberta, Canada, Calgary
Co-Investments: 1
EI
North America, Texas, United States, Dallas
Co-Investments: 1
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 1
Qiagen
Europe, Limburg, The Netherlands, Venlo
Co-Investments: 1
LP
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by CTI Capital?

Wattio

San Sebastian, Pais Vasco, Spain

Wattio is a SmartHome solution that combines gadgets, apps and a full automation system.

Consumer ElectronicsHardwareSoftware
Series UnknownJan 18, 2022
Amount Raised: $192,585
Xagenic

Toronto, Ontario, Canada

Xagenic is a molecular diagnostics company developing on-demand molecular testing, facilitating faster treatment decisions for patients.

BiotechnologyHealth DiagnosticsMedical Device
Series BJul 14, 2014
Amount Raised: $25,500,000
Xagenic

Toronto, Ontario, Canada

Xagenic is a molecular diagnostics company developing on-demand molecular testing, facilitating faster treatment decisions for patients.

BiotechnologyHealth DiagnosticsMedical Device
Series AJan 30, 2012
Amount Raised: $10,000,000
Enobia Pharma

Montreal, Quebec, Canada

Enobia Pharma develops therapies for the treatment of serious genetic bone disorders.

BiotechnologyGeneticsHealth CareMedical
Series CAug 10, 2009
Amount Raised: $50,000,000
BeXcom

Singapore, Central Region, Singapore

BeXcom, a privately held corporation founded in 1996, operates a global network of eCommerce hubs in the world's major trading zones.

B2BE-CommerceLogistics
Series UnknownMar 31, 2000
Amount Raised: $75,000,000